Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.

Ma, Shu-Juan; Zheng, Yi-Xiang; Zhou, Peng-Cheng; Xiao, Yan-Ni; Tan, Hong-Zhuan

Ma, Shu-Juan; Zheng, Yi-Xiang; Zhou, Peng-Cheng; Xiao, Yan-Ni; Tan, Hong-Zhuan.

Afiliación

Ma SJ; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Zheng YX; Department of Infectious Disease, Viral Hepatitis Key Laboratory of Hunan Province, Xiangya Hospital, Central South University, Changsha, China.
Zhou PC; Department of Infectious Disease, Viral Hepatitis Key Laboratory of Hunan Province, Xiangya Hospital, Central South University, Changsha, China.
Xiao YN; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.
Tan HZ; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China.

Oncotarget ; 7(40): 66202-66211, 2016 Oct 04.

Article en En | MEDLINE | ID: mdl-27494848

Asunto(s)

Diabetes Mellitus Tipo 2/tratamiento farmacológico; Hipoglucemiantes/uso terapéutico; Neoplasias Hepáticas/tratamiento farmacológico; Metformina/uso terapéutico; Diabetes Mellitus Tipo 2/complicaciones; Humanos; Neoplasias Hepáticas/complicaciones; Pronóstico

Palabras clave

diabetes mellitus; liver cancer; meta-analysis; metformin; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hipoglucemiantes / Neoplasias Hepáticas / Metformina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google